Narrative review / 2015
A review discusses diet, gut microbiota-derived TMAO, and cardiovascular concerns in nondialysis chronic kidney disease patients.
This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.
- Study type
- Narrative review
- Who was studied
- Nondialysis chronic kidney disease patients
- What was measured
- Relationship between TMAO, diet, and cardiovascular aspects in CKD patients
THE PAPER
Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.
Moraes C, Fouque D, Amaral AC, Mafra D. J Ren Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.